Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Bladder cancer
Trial Status:  Active
Results 1-25 of 247 for your search:
Start Over
Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: URO-OBT-01, NCT01446822
Integrating Tobacco Treatment Into Cancer Care: A Randomized Controlled Comparative Effectiveness Trial
Phase: Phase IV
Type: Behavioral study, Biomarker/Laboratory analysis, Health services research
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2013P001036, 1R01CA166147-01A1, NCT01871506
Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications
Phase: Phase IV
Type: Supportive care
Status: Approved-not yet active
Age: 19 to 70
Sponsor: Other
Protocol IDs: No, NCT01876836
Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.
Phase: Phase IV
Type: Supportive care, Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: EC/2013/472, 2013-000782-36, NCT02001857
Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer
Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: AEl-Sawy172014, NCT02214602
Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer
Phase: Phase IV
Type: Health services research, Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 4B-14-4, NCI-2015-00279, P30CA014089, NCT02438852
Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 40 to 80
Sponsor: Other
Protocol IDs: 16.02.2015 20/03, NCT02443844
Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: RRK4368, 2012-002552-16, NCT01668459
Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Secavin-12, NCT01830231
Tranexamic Acid During Cystectomy Trial (TACT) Pilot Study
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CIHR MOP-123361, Control # 162042, NCT01869413
A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function.
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 13 URO 02, NCT02240017
Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: B9E-MC-S062, AB 22/00, NCT00146276
Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000602239, UZG-CUL-UHG-Non-InvasiveBladde, EU-20870, UZG-CUL-UHG-Non-InvasiveBladderCancer, CUL-UHG-Non-Invasive Bladder Cancer, NCT00729287
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer
Phase: Phase III
Type: Health services research, Supportive care
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000667367, RMH-CCR3086, EUDRACT-2008-002152-26, EU-21010, MREC-08/H0903/40, NCT01087268
S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: S1011, SWOG-S1011, NCT01224665
Managing Cancer and Living Meaningfully (CALM): A Study to Evaluate the Effectiveness of a Psychological Intervention for Cancer Patients
Phase: Phase III
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492
Efficacy of Diclofenac BCG Irrigations
Phase: Phase III
Type: Supportive care
Status: Approved-not yet active
Age: 20 to 80
Sponsor: Other
Protocol IDs: CMC-11-0015-CTIL, NCT01542567
Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder Tumor
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CUHK_TURB_2012, NCT01581723
Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: FinnBladder 9, 2012-000559-15, NCT01675219
Perioperative Chemotherapy for Patients With Locally Advanced Bladder Cancer
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 2011/119/HP, NCT01812369
Study Comparing Early and Late Nutrition in Cancer Patients Undergoing Abdominal Surgery
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ICESP, NCT01839617
A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine
Phase: Phase III
Type: Diagnostic
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: E-13-1019, 14/4028/IRB, NCT02101931
Therapeutic Instillation of Mistletoe
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: AB03, 2013-003446-16, NCT02106572
A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy
Phase: Phase III
Type: Supportive care
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: 14-069, NCT02145871
Start Over